Corticosteroids injections versus corticosteroids with hyaluronic acid injections in rhizarthrosis: the randomised multicentre RHIZ'ART trial study protocol.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
09 01 2019
Historique:
entrez: 21 2 2019
pubmed: 21 2 2019
medline: 30 1 2020
Statut: epublish

Résumé

Osteoarthritis of the trapeziometacarpal joint affects approximately 10%-25% of women, especially those who are postmenopausal. It may result in thumb dysfunction. Among the treatments, intra-articular injections of corticosteroid (CS) and hyaluronic acid (HA) are both effective and recommended. However, clinical trials have shown that HA improves functional capacity, whereas CS only produces a decrease in pain. The synergy of these two drugs has not been evaluated. The primary goal of this study was to determine whether the association between HA and CS produce an additional decrease of more pain during thumb movement at three months postinjection, compared to the level of pain relief from CS alone. RHIZ'ART is a prospective, multicentre, comparative, randomised, controlled, double-blind trial. Patients referred to the rheumatology department for thumb rhizarthrosis will receive an injection of betamethasone with HA or placebo (serum saline) based on central randomisation and stratification by centre. Injections will be given under ultrasound guidance. The primary outcome will compare the pain Visual Analogue Scale with motion at three months for both groups using a mixed model. The expected decrease in pain intensity in the CS group is 25% and 35% in the CS with HA group. In order to achieve a 80% power for detecting this difference with α set at 5%, 73 patients are needed in each group (146 total). The main secondary outcomes are the Cochin score (hand function) and grip strength. Follow-up visits are at 1, 3, 6 and 12 months. The study project has been approved by the appropriate ethics committee (CPP île de France III, 2017-002298-20). In agreement with current French regulations, a signed informed written consent will be obtained from each patient. Results of the main trial and of the secondary endpoints will be submitted for publication in a peer-reviewed journal. NCT03431584.

Identifiants

pubmed: 30782680
pii: bmjopen-2018-022553
doi: 10.1136/bmjopen-2018-022553
pmc: PMC6340006
doi:

Substances chimiques

Adrenal Cortex Hormones 0
Hyaluronic Acid 9004-61-9

Banques de données

ClinicalTrials.gov
['NCT03431584']

Types de publication

Clinical Trial Protocol Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e022553

Informations de copyright

© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

J Hand Surg Am. 2008 Jan;33(1):40-8
pubmed: 18261664
Osteoarthritis Cartilage. 2006 Jan;14(1):82-8
pubmed: 16242353
BMJ. 2013 Jan 08;346:e7586
pubmed: 23303884
Drugs Aging. 2016 Feb;33(2):119-33
pubmed: 26650235
Rheumatol Int. 2006 Feb;26(4):314-9
pubmed: 15703953
Joint Bone Spine. 2015 Oct;82(5):315-9
pubmed: 25776442
Clin Rheumatol. 2011 Sep;30(9):1195-200
pubmed: 21424690
BMC Vet Res. 2015 Dec 04;11:298
pubmed: 26637428
BMC Musculoskelet Disord. 2010 May 19;11:94
pubmed: 20482832
Ann Rheum Dis. 2007 Mar;66(3):377-88
pubmed: 17046965
J Hand Surg Br. 1994 Jun;19(3):340-1
pubmed: 8077824
J Clin Rheumatol. 2005 Dec;11(6):299-302
pubmed: 16371798
Ann Rheum Dis. 2004 Oct;63(10):1260-3
pubmed: 15361383
Joint Bone Spine. 2015 Mar;82(2):116-21
pubmed: 25311256
BMC Musculoskelet Disord. 2015 Mar 18;16:57
pubmed: 25887932
Clin Rheumatol. 2009 May;28(5):529-33
pubmed: 19137353
Osteoarthritis Cartilage. 2001 Aug;9(6):570-7
pubmed: 11520171
Joint Bone Spine. 2007 Jul;74(4):368-72
pubmed: 17590369

Auteurs

Grégoire Cormier (G)

Service de Rhumatologie, CHD Vendée, La Roche-sur-Yon, France.

Benoit Le Goff (B)

Service de Rhumatologie, CHU Nantes, Nantes, France.

Amélie Denis (A)

Service de Rhumatologie, CH Le Mans, Le Mans, Pays de la Loire, France.

Stéphane Varin (S)

Service de Rhumatologie, CHD Vendée, La Roche-sur-Yon, France.

Lucie Auzanneau (L)

Methodologist, centre de Recherche Clinique, CHD Vendée, La Roche-sur-Yon, Pays de la Loire, France.

Jérôme Dimet (J)

Methodologist, centre de Recherche Clinique, CHD Vendée, La Roche-sur-Yon, Pays de la Loire, France.

Aurélie Le Thuaut (A)

Methodologist, centre de Recherche Clinique, CHD Vendée, La Roche-sur-Yon, Pays de la Loire, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH